Summary

The global POC Diagnostics market is projected to grow from US$ 22686 million in 2025 to US$ 36878 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
POC Diagnostics refers to in vitro diagnostic testing performed at or near the patient location to provide clinically actionable results without relying solely on conventional centralized laboratory workflows. The market covers clinical chemistry and blood gas testing, immunoassay, molecular diagnostics, hematology, coagulation, and urinalysis performed through POC instruments, analyzers, test cartridges, reagents, test kits, and related consumables. Product formats range from handheld and portable systems to compact benchtop analyzers and instrument-free rapid tests, supporting qualitative, semi-quantitative, and quantitative testing. The defining attributes of POC Diagnostics are shorter sample-to-result workflows, simplified operation, limited sample handling, and deployment outside or alongside central laboratories. Core applications include hospitals, physician offices and clinics, emergency and critical care, ambulatory care, community health facilities, pharmacies and retail clinics, and home care. This study focuses on diagnostic products designed to move testing closer to clinical decision points and enable decentralized disease screening, diagnosis, monitoring, and treatment guidance.
Key Findings
POC Diagnostics shifts laboratory testing closer to patients and clinical decisions
Portable and compact systems remain central to decentralized diagnostic workflows
Reagents and consumables anchor recurring demand across installed testing platforms
Molecular POC testing is advancing toward compact multiplex near-patient platforms
Hospitals remain core users while outpatient and home settings expand
Market Trends
POC Diagnostics is evolving from relatively simple single-analyte rapid testing toward integrated platforms combining broader test menus, higher analytical capability, simplified sample preparation, digital connectivity, and automated quality control. Miniaturization and cartridge-based system design are reducing the operational complexity associated with near-patient testing, while multiplex molecular technologies are extending POC applications from traditional blood chemistry, immunoassay, and infectious disease screening into more comprehensive syndromic testing. At the same time, healthcare providers are placing greater emphasis on connectivity with laboratory and hospital information systems, centralized operator management, traceability, and quality assurance. The longer-term direction is therefore not simply faster testing, but a transition toward connected decentralized diagnostic networks in which instruments, consumables, software, and clinical workflows are increasingly integrated. This favors platforms that can combine rapid turnaround, broader menus, workflow simplicity, and consistent analytical performance rather than products competing primarily on test speed alone.
Market Dynamics
Drivers
Demand for POC Diagnostics is supported by the need to shorten clinical decision cycles in emergency medicine, critical care, outpatient treatment, infectious disease management, and chronic disease monitoring. Decentralized testing can reduce sample transportation and laboratory waiting time and allows clinicians to obtain diagnostic information closer to the moment of treatment. The expansion of outpatient healthcare, community-based services, retail healthcare, and home care is also increasing the number of settings in which conventional central-laboratory workflows are less practical. In parallel, improvements in biosensors, immunoassay formats, microfluidics, molecular amplification, disposable cartridges, and portable electronics are making more sophisticated tests technically feasible outside the central laboratory. These factors are expanding POC Diagnostics from a limited set of rapid tests into a broader diagnostic infrastructure supporting both acute and routine care.
Restraints
The main constraints on POC Diagnostics arise from economics, quality management, and clinical performance requirements. Although decentralized testing can shorten turnaround times, per-test consumable costs can be higher than high-volume central laboratory testing, particularly for low-throughput sites. Healthcare providers must also manage instrument maintenance, calibration, quality control, operator training, reagent storage, and inventory across dispersed testing locations. The economic value of a POC platform therefore depends on whether faster clinical decisions offset higher testing and operational costs. In addition, certain complex assays remain better suited to centralized laboratories because of analytical sensitivity, throughput, specialist interpretation, or sample-processing requirements. Reimbursement differences and varying regulatory requirements among countries further influence the pace at which new POC technologies can be adopted.
Opportunities
The strongest opportunities are emerging at the intersection of molecular diagnostics, multiplex testing, portable instrumentation, and connected healthcare. Compact molecular systems can bring pathogen detection and syndromic testing closer to physician offices, urgent care, emergency departments, and other decentralized environments, while expanding assay menus can increase utilization of installed instruments. Further opportunities exist in community health, retail clinics, pharmacies, and home care, where simple sample collection and automated result interpretation can support broader access to testing. Emerging healthcare markets also provide room for portable systems that require less laboratory infrastructure. From a business-model perspective, platforms combining an installed analyzer base with recurring cartridges, reagents, software, and connectivity services can create stronger customer relationships and more predictable recurring demand than standalone disposable tests.
Challenges
The industry must balance decentralization with laboratory-grade quality and governance. As testing moves across hospitals, clinics, pharmacies, community facilities, and homes, maintaining consistent sample collection, operator competency, quality control, result interpretation, and device performance becomes more complex. Manufacturers must also address interoperability with laboratory and hospital information systems, cybersecurity, data management, and differences in national regulatory requirements. Broader test menus increase platform value but also raise assay-development, validation, manufacturing, and regulatory complexity. Another long-term challenge is avoiding unnecessary duplication between POC and central laboratory testing; healthcare systems increasingly evaluate diagnostic technologies on their ability to improve total clinical workflow and patient management rather than on analytical speed alone.
Industry Chain Analysis
The upstream POC Diagnostics industry includes biological and chemical raw materials such as antibodies, antigens, enzymes, primers, probes, substrates, buffers, and control materials, together with membranes, microfluidic components, electrochemical and optical sensors, plastic consumables, electronic components, and specialized packaging. Performance consistency of these inputs directly affects assay sensitivity, stability, shelf life, and manufacturing reproducibility. Midstream activities combine assay development, reagent formulation, cartridge or test-strip production, analyzer engineering, software development, system integration, calibration, quality management, and regulatory compliance. Manufacturing capability is particularly important because POC products must translate laboratory analytical methods into robust workflows that can be operated by a broader range of users.
Downstream value is created through deployment in hospitals, physician offices, emergency and critical care units, ambulatory facilities, community health centers, pharmacies, retail clinics, and home environments. Instruments establish the testing platform, while reagents, cartridges, test kits, and other consumables generate recurring demand throughout the installed life of the system. Digital connectivity and data-management capabilities increasingly add value by linking decentralized instruments with centralized quality control and clinical information systems. As a result, competitive advantage increasingly depends on the combined performance of assays, instruments, consumables, workflow design, service capability, and informatics rather than on any single hardware component.
Segment Insights
By testing discipline, clinical chemistry and blood gas, immunoassay, molecular diagnostics, hematology, coagulation, and urinalysis represent distinct POC technology segments with different clinical requirements and purchasing patterns. Clinical chemistry and blood gas systems are closely linked to acute and critical-care workflows, while immunoassay platforms address a broad range of cardiac, inflammatory, metabolic, infectious disease, and other biomarkers. Molecular POC represents an important technology-upgrade direction because compact amplification systems can deliver more specific pathogen identification and multiplex testing near the patient. Hematology, coagulation, and urinalysis retain strong value in applications where rapid monitoring can directly influence treatment decisions.
From a product perspective, instruments and analyzers create the installed platform, while reagents, test kits, cartridges, and consumables constitute the recurring-use component of the market. Handheld and portable systems are particularly suited to bedside, emergency, community, and mobile applications, whereas compact benchtop systems can support broader menus and higher testing frequency in clinics and decentralized laboratory environments. Instrument-free rapid tests remain relevant where simplicity, accessibility, and low infrastructure requirements are more important than connectivity or quantitative analytical capability.
Downstream Market Opportunities
Hospitals remain a core application environment because emergency departments, intensive care units, operating rooms, and other time-sensitive clinical settings derive direct value from rapid access to diagnostic results. Growth opportunities are increasingly extending beyond hospitals as physician offices, urgent and ambulatory care centers, community health facilities, pharmacies, retail clinics, and home-care environments adopt decentralized testing. These settings favor technologies requiring limited sample preparation, minimal operator training, compact equipment, and simple result interpretation. The commercial opportunity is therefore shifting from supplying isolated rapid tests toward supporting distributed diagnostic networks in which different care settings use standardized platforms, connected data systems, and recurring consumables to manage screening, diagnosis, monitoring, and follow-up closer to patients.
Regional Insights
Regional development of POC Diagnostics reflects differences in healthcare infrastructure, reimbursement, regulatory frameworks, laboratory organization, and access to medical services. North America and Europe are relatively mature adoption environments, with established hospital laboratory networks and significant use of decentralized testing in emergency, critical-care, physician-office, and outpatient settings. Regulatory requirements and quality-management expectations in these regions favor products that combine ease of use with traceability, operator controls, connectivity, and documented analytical performance. Replacement of earlier-generation systems and expansion of menus on existing platforms remain important commercial opportunities.
Asia-Pacific presents a more heterogeneous opportunity structure. Developed healthcare markets emphasize workflow efficiency, compact automation, and integration with hospital information systems, while emerging markets can benefit from portable and lower-infrastructure diagnostic solutions that extend testing beyond major laboratories. China also has an established domestic POC manufacturing base, particularly in rapid immunoassay and compact analyzer platforms, increasing competition in product localization and cost efficiency. Across other emerging regions, access to diagnostics, distribution capability, reagent stability, service coverage, and affordability remain critical determinants of market penetration.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global POC Diagnostics market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Bio-Rad Laboratories
Nova Biomedical
QuidelOrtho
Werfen
OraSure Technologies
Helena Laboratories
Phamatech
Chembio Diagnostics
Trinity Biotech
Wuhan Easy Diagnosis
Intec PRODUCT
Sinocare
Wondfo
Getein Biotech
Segment by Type
Consumables
Devices
Segment by Result Format
Qualitative POC Tests
Semi-quantitative POC Tests
Quantitative POC Tests
Segment by Testing Discipline
Clinical Chemistry & Blood Gas POC Diagnostics
Immunoassay POC Diagnostics
Molecular POC Diagnostics
Hematology POC Diagnostics
Coagulation POC Diagnostics
Urinalysis POC Diagnostics
Segment by Application
Hospital & Clinic
Laboratory
Household
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the POC Diagnostics study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to POC Diagnostics: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global POC Diagnostics Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Consumables
1.2.3 Devices
1.3 Market Segmentation by Result Format
1.3.1 Global POC Diagnostics Market Size by Result Format, 2021 vs 2025 vs 2032
1.3.2 Qualitative POC Tests
1.3.3 Semi-quantitative POC Tests
1.3.4 Quantitative POC Tests
1.4 Market Segmentation by Testing Discipline
1.4.1 Global POC Diagnostics Market Size by Testing Discipline, 2021 vs 2025 vs 2032
1.4.2 Clinical Chemistry & Blood Gas POC Diagnostics
1.4.3 Immunoassay POC Diagnostics
1.4.4 Molecular POC Diagnostics
1.4.5 Hematology POC Diagnostics
1.4.6 Coagulation POC Diagnostics
1.4.7 Urinalysis POC Diagnostics
1.5 Market Segmentation by Application
1.5.1 Global POC Diagnostics Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Hospital & Clinic
1.5.3 Laboratory
1.5.4 Household
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global POC Diagnostics Revenue Estimates and Forecasts (2021-2032)
2.2 Global POC Diagnostics Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global POC Diagnostics Sales Estimates and Forecasts (2021-2032)
2.4 Global POC Diagnostics Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global POC Diagnostics Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global POC Diagnostics Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Consumables: Market Share by Key Manufacturers
3.5.2 Devices: Market Share by Key Manufacturers
3.6 Global POC Diagnostics Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global POC Diagnostics Sales Performance by Type
4.1.1 Global POC Diagnostics Sales Volume by Type (2021-2032)
4.1.2 Global POC Diagnostics Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global POC Diagnostics Sales Performance by Result Format
4.2.1 Global POC Diagnostics Sales Volume by Result Format (2021-2032)
4.2.2 Global POC Diagnostics Revenue by Result Format (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Result Format (2021-2032)
4.3 Global POC Diagnostics Sales Performance by Testing Discipline
4.3.1 Global POC Diagnostics Sales Volume by Testing Discipline (2021-2032)
4.3.2 Global POC Diagnostics Revenue by Testing Discipline (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Testing Discipline (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global POC Diagnostics Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global POC Diagnostics Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America POC Diagnostics Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America POC Diagnostics Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe POC Diagnostics Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe POC Diagnostics Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific POC Diagnostics Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific POC Diagnostics Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America POC Diagnostics Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America POC Diagnostics Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa POC Diagnostics Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa POC Diagnostics Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche POC Diagnostics Product Models, Descriptions and Specifications
11.1.4 Roche POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Roche POC Diagnostics Sales by Product in 2025
11.1.6 Roche POC Diagnostics Sales by Application in 2025
11.1.7 Roche POC Diagnostics Sales by Geographic Area in 2025
11.1.8 Roche POC Diagnostics SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott POC Diagnostics Product Models, Descriptions and Specifications
11.2.4 Abbott POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Abbott POC Diagnostics Sales by Product in 2025
11.2.6 Abbott POC Diagnostics Sales by Application in 2025
11.2.7 Abbott POC Diagnostics Sales by Geographic Area in 2025
11.2.8 Abbott POC Diagnostics SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 LifeScan
11.3.1 LifeScan Corporation Information
11.3.2 LifeScan Business Overview
11.3.3 LifeScan POC Diagnostics Product Models, Descriptions and Specifications
11.3.4 LifeScan POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 LifeScan POC Diagnostics Sales by Product in 2025
11.3.6 LifeScan POC Diagnostics Sales by Application in 2025
11.3.7 LifeScan POC Diagnostics Sales by Geographic Area in 2025
11.3.8 LifeScan POC Diagnostics SWOT Analysis
11.3.9 LifeScan Recent Developments
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Corporation Information
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers POC Diagnostics Product Models, Descriptions and Specifications
11.4.4 Siemens Healthineers POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Siemens Healthineers POC Diagnostics Sales by Product in 2025
11.4.6 Siemens Healthineers POC Diagnostics Sales by Application in 2025
11.4.7 Siemens Healthineers POC Diagnostics Sales by Geographic Area in 2025
11.4.8 Siemens Healthineers POC Diagnostics SWOT Analysis
11.4.9 Siemens Healthineers Recent Developments
11.5 Danaher
11.5.1 Danaher Corporation Information
11.5.2 Danaher Business Overview
11.5.3 Danaher POC Diagnostics Product Models, Descriptions and Specifications
11.5.4 Danaher POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Danaher POC Diagnostics Sales by Product in 2025
11.5.6 Danaher POC Diagnostics Sales by Application in 2025
11.5.7 Danaher POC Diagnostics Sales by Geographic Area in 2025
11.5.8 Danaher POC Diagnostics SWOT Analysis
11.5.9 Danaher Recent Developments
11.6 Ascensia
11.6.1 Ascensia Corporation Information
11.6.2 Ascensia Business Overview
11.6.3 Ascensia POC Diagnostics Product Models, Descriptions and Specifications
11.6.4 Ascensia POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Ascensia Recent Developments
11.7 BioMerieux
11.7.1 BioMerieux Corporation Information
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux POC Diagnostics Product Models, Descriptions and Specifications
11.7.4 BioMerieux POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 BioMerieux Recent Developments
11.8 ARKRAY
11.8.1 ARKRAY Corporation Information
11.8.2 ARKRAY Business Overview
11.8.3 ARKRAY POC Diagnostics Product Models, Descriptions and Specifications
11.8.4 ARKRAY POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 ARKRAY Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Corporation Information
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories POC Diagnostics Product Models, Descriptions and Specifications
11.9.4 Bio-Rad Laboratories POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Nova Biomedical
11.10.1 Nova Biomedical Corporation Information
11.10.2 Nova Biomedical Business Overview
11.10.3 Nova Biomedical POC Diagnostics Product Models, Descriptions and Specifications
11.10.4 Nova Biomedical POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Nova Biomedical Recent Developments
11.11 QuidelOrtho
11.11.1 QuidelOrtho Corporation Information
11.11.2 QuidelOrtho Business Overview
11.11.3 QuidelOrtho POC Diagnostics Product Models, Descriptions and Specifications
11.11.4 QuidelOrtho POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 QuidelOrtho Recent Developments
11.12 Werfen
11.12.1 Werfen Corporation Information
11.12.2 Werfen Business Overview
11.12.3 Werfen POC Diagnostics Product Models, Descriptions and Specifications
11.12.4 Werfen POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Werfen Recent Developments
11.13 OraSure Technologies
11.13.1 OraSure Technologies Corporation Information
11.13.2 OraSure Technologies Business Overview
11.13.3 OraSure Technologies POC Diagnostics Product Models, Descriptions and Specifications
11.13.4 OraSure Technologies POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 OraSure Technologies Recent Developments
11.14 Helena Laboratories
11.14.1 Helena Laboratories Corporation Information
11.14.2 Helena Laboratories Business Overview
11.14.3 Helena Laboratories POC Diagnostics Product Models, Descriptions and Specifications
11.14.4 Helena Laboratories POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Helena Laboratories Recent Developments
11.15 Phamatech
11.15.1 Phamatech Corporation Information
11.15.2 Phamatech Business Overview
11.15.3 Phamatech POC Diagnostics Product Models, Descriptions and Specifications
11.15.4 Phamatech POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Phamatech Recent Developments
11.16 Chembio Diagnostics
11.16.1 Chembio Diagnostics Corporation Information
11.16.2 Chembio Diagnostics Business Overview
11.16.3 Chembio Diagnostics POC Diagnostics Product Models, Descriptions and Specifications
11.16.4 Chembio Diagnostics POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Chembio Diagnostics Recent Developments
11.17 Trinity Biotech
11.17.1 Trinity Biotech Corporation Information
11.17.2 Trinity Biotech Business Overview
11.17.3 Trinity Biotech POC Diagnostics Product Models, Descriptions and Specifications
11.17.4 Trinity Biotech POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Trinity Biotech Recent Developments
11.18 Wuhan Easy Diagnosis
11.18.1 Wuhan Easy Diagnosis Corporation Information
11.18.2 Wuhan Easy Diagnosis Business Overview
11.18.3 Wuhan Easy Diagnosis POC Diagnostics Product Models, Descriptions and Specifications
11.18.4 Wuhan Easy Diagnosis POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 Wuhan Easy Diagnosis Recent Developments
11.19 Intec PRODUCT
11.19.1 Intec PRODUCT Corporation Information
11.19.2 Intec PRODUCT Business Overview
11.19.3 Intec PRODUCT POC Diagnostics Product Models, Descriptions and Specifications
11.19.4 Intec PRODUCT POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Intec PRODUCT Recent Developments
11.20 Sinocare
11.20.1 Sinocare Corporation Information
11.20.2 Sinocare Business Overview
11.20.3 Sinocare POC Diagnostics Product Models, Descriptions and Specifications
11.20.4 Sinocare POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.20.5 Sinocare Recent Developments
11.21 Wondfo
11.21.1 Wondfo Corporation Information
11.21.2 Wondfo Business Overview
11.21.3 Wondfo POC Diagnostics Product Models, Descriptions and Specifications
11.21.4 Wondfo POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.21.5 Wondfo Recent Developments
11.22 Getein Biotech
11.22.1 Getein Biotech Corporation Information
11.22.2 Getein Biotech Business Overview
11.22.3 Getein Biotech POC Diagnostics Product Models, Descriptions and Specifications
11.22.4 Getein Biotech POC Diagnostics Sales, Price, Revenue and Gross Margin (2021-2026)
11.22.5 Getein Biotech Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 POC Diagnostics Industry Chain
12.2 POC Diagnostics Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 POC Diagnostics Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 POC Diagnostics Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 POC Diagnostics Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global POC Diagnostics Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global POC Diagnostics Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global POC Diagnostics Market Size Growth Rate by Result Format, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global POC Diagnostics Market Size Growth Rate by Testing Discipline, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global POC Diagnostics Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global POC Diagnostics Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global POC Diagnostics Revenue by Region (US$ Million), 2021-2026
Table 7. Global POC Diagnostics Revenue by Region (US$ Million), 2027-2032
Table 8. Global POC Diagnostics Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global POC Diagnostics Sales by Region (K Units), 2021-2026
Table 10. Global POC Diagnostics Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global POC Diagnostics Sales by Manufacturers (K Units), 2021-2026
Table 13. Global POC Diagnostics Sales Share by Manufacturers (2021-2026)
Table 14. Global POC Diagnostics Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global POC Diagnostics Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on POC Diagnostics Revenue, 2025
Table 18. Global POC Diagnostics Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global POC Diagnostics Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers POC Diagnostics Manufacturing Base and Headquarters
Table 21. Global POC Diagnostics Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global POC Diagnostics Sales Volume by Type (K Units), 2021-2026
Table 25. Global POC Diagnostics Sales Volume by Type (K Units), 2027-2032
Table 26. Global POC Diagnostics Revenue by Type (US$ Million), 2021-2026
Table 27. Global POC Diagnostics Revenue by Type (US$ Million), 2027-2032
Table 28. Global POC Diagnostics Sales Volume by Result Format (K Units), 2021-2026
Table 29. Global POC Diagnostics Sales Volume by Result Format (K Units), 2027-2032
Table 30. Global POC Diagnostics Revenue by Result Format (US$ Million), 2021-2026
Table 31. Global POC Diagnostics Revenue by Result Format (US$ Million), 2027-2032
Table 32. Global POC Diagnostics Sales Volume by Testing Discipline (K Units), 2021-2026
Table 33. Global POC Diagnostics Sales Volume by Testing Discipline (K Units), 2027-2032
Table 34. Global POC Diagnostics Revenue by Testing Discipline (US$ Million), 2021-2026
Table 35. Global POC Diagnostics Revenue by Testing Discipline (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global POC Diagnostics Sales by Application (K Units), 2021-2026
Table 38. Global POC Diagnostics Sales by Application (K Units), 2027-2032
Table 39. POC Diagnostics High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global POC Diagnostics Revenue by Application (US$ Million), 2021-2026
Table 41. Global POC Diagnostics Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America POC Diagnostics Growth Accelerators and Market Barriers
Table 45. North America POC Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America POC Diagnostics Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe POC Diagnostics Growth Accelerators and Market Barriers
Table 48. Europe POC Diagnostics Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe POC Diagnostics Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific POC Diagnostics Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific POC Diagnostics Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific POC Diagnostics Growth Accelerators and Market Barriers
Table 53. Southeast Asia POC Diagnostics Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America POC Diagnostics Investment Opportunities and Key Challenges
Table 55. Central and South America POC Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa POC Diagnostics Investment Opportunities and Key Challenges
Table 57. Middle East and Africa POC Diagnostics Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Roche Corporation Information
Table 59. Roche Description and Major Businesses
Table 60. Roche Product Models, Descriptions and Specifications
Table 61. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Roche Sales Value Proportion by Product in 2025
Table 63. Roche Sales Value Proportion by Application in 2025
Table 64. Roche Sales Value Proportion by Geographic Area in 2025
Table 65. Roche POC Diagnostics SWOT Analysis
Table 66. Roche Recent Developments
Table 67. Abbott Corporation Information
Table 68. Abbott Description and Major Businesses
Table 69. Abbott Product Models, Descriptions and Specifications
Table 70. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Abbott Sales Value Proportion by Product in 2025
Table 72. Abbott Sales Value Proportion by Application in 2025
Table 73. Abbott Sales Value Proportion by Geographic Area in 2025
Table 74. Abbott POC Diagnostics SWOT Analysis
Table 75. Abbott Recent Developments
Table 76. LifeScan Corporation Information
Table 77. LifeScan Description and Major Businesses
Table 78. LifeScan Product Models, Descriptions and Specifications
Table 79. LifeScan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. LifeScan Sales Value Proportion by Product in 2025
Table 81. LifeScan Sales Value Proportion by Application in 2025
Table 82. LifeScan Sales Value Proportion by Geographic Area in 2025
Table 83. LifeScan POC Diagnostics SWOT Analysis
Table 84. LifeScan Recent Developments
Table 85. Siemens Healthineers Corporation Information
Table 86. Siemens Healthineers Description and Major Businesses
Table 87. Siemens Healthineers Product Models, Descriptions and Specifications
Table 88. Siemens Healthineers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Siemens Healthineers Sales Value Proportion by Product in 2025
Table 90. Siemens Healthineers Sales Value Proportion by Application in 2025
Table 91. Siemens Healthineers Sales Value Proportion by Geographic Area in 2025
Table 92. Siemens Healthineers POC Diagnostics SWOT Analysis
Table 93. Siemens Healthineers Recent Developments
Table 94. Danaher Corporation Information
Table 95. Danaher Description and Major Businesses
Table 96. Danaher Product Models, Descriptions and Specifications
Table 97. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Danaher Sales Value Proportion by Product in 2025
Table 99. Danaher Sales Value Proportion by Application in 2025
Table 100. Danaher Sales Value Proportion by Geographic Area in 2025
Table 101. Danaher POC Diagnostics SWOT Analysis
Table 102. Danaher Recent Developments
Table 103. Ascensia Corporation Information
Table 104. Ascensia Description and Major Businesses
Table 105. Ascensia Product Models, Descriptions and Specifications
Table 106. Ascensia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Ascensia Recent Developments
Table 108. BioMerieux Corporation Information
Table 109. BioMerieux Description and Major Businesses
Table 110. BioMerieux Product Models, Descriptions and Specifications
Table 111. BioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. BioMerieux Recent Developments
Table 113. ARKRAY Corporation Information
Table 114. ARKRAY Description and Major Businesses
Table 115. ARKRAY Product Models, Descriptions and Specifications
Table 116. ARKRAY Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. ARKRAY Recent Developments
Table 118. Bio-Rad Laboratories Corporation Information
Table 119. Bio-Rad Laboratories Description and Major Businesses
Table 120. Bio-Rad Laboratories Product Models, Descriptions and Specifications
Table 121. Bio-Rad Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Bio-Rad Laboratories Recent Developments
Table 123. Nova Biomedical Corporation Information
Table 124. Nova Biomedical Description and Major Businesses
Table 125. Nova Biomedical Product Models, Descriptions and Specifications
Table 126. Nova Biomedical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Nova Biomedical Recent Developments
Table 128. QuidelOrtho Corporation Information
Table 129. QuidelOrtho Description and Major Businesses
Table 130. QuidelOrtho Product Models, Descriptions and Specifications
Table 131. QuidelOrtho Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. QuidelOrtho Recent Developments
Table 133. Werfen Corporation Information
Table 134. Werfen Description and Major Businesses
Table 135. Werfen Product Models, Descriptions and Specifications
Table 136. Werfen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Werfen Recent Developments
Table 138. OraSure Technologies Corporation Information
Table 139. OraSure Technologies Description and Major Businesses
Table 140. OraSure Technologies Product Models, Descriptions and Specifications
Table 141. OraSure Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. OraSure Technologies Recent Developments
Table 143. Helena Laboratories Corporation Information
Table 144. Helena Laboratories Description and Major Businesses
Table 145. Helena Laboratories Product Models, Descriptions and Specifications
Table 146. Helena Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Helena Laboratories Recent Developments
Table 148. Phamatech Corporation Information
Table 149. Phamatech Description and Major Businesses
Table 150. Phamatech Product Models, Descriptions and Specifications
Table 151. Phamatech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Phamatech Recent Developments
Table 153. Chembio Diagnostics Corporation Information
Table 154. Chembio Diagnostics Description and Major Businesses
Table 155. Chembio Diagnostics Product Models, Descriptions and Specifications
Table 156. Chembio Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Chembio Diagnostics Recent Developments
Table 158. Trinity Biotech Corporation Information
Table 159. Trinity Biotech Description and Major Businesses
Table 160. Trinity Biotech Product Models, Descriptions and Specifications
Table 161. Trinity Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Trinity Biotech Recent Developments
Table 163. Wuhan Easy Diagnosis Corporation Information
Table 164. Wuhan Easy Diagnosis Description and Major Businesses
Table 165. Wuhan Easy Diagnosis Product Models, Descriptions and Specifications
Table 166. Wuhan Easy Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Wuhan Easy Diagnosis Recent Developments
Table 168. Intec PRODUCT Corporation Information
Table 169. Intec PRODUCT Description and Major Businesses
Table 170. Intec PRODUCT Product Models, Descriptions and Specifications
Table 171. Intec PRODUCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Intec PRODUCT Recent Developments
Table 173. Sinocare Corporation Information
Table 174. Sinocare Description and Major Businesses
Table 175. Sinocare Product Models, Descriptions and Specifications
Table 176. Sinocare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Sinocare Recent Developments
Table 178. Wondfo Corporation Information
Table 179. Wondfo Description and Major Businesses
Table 180. Wondfo Product Models, Descriptions and Specifications
Table 181. Wondfo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Wondfo Recent Developments
Table 183. Getein Biotech Corporation Information
Table 184. Getein Biotech Description and Major Businesses
Table 185. Getein Biotech Product Models, Descriptions and Specifications
Table 186. Getein Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Getein Biotech Recent Developments
Table 188. Key Raw Materials Distribution
Table 189. Raw Materials Key Suppliers
Table 190. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 191. Milestones in Production Technology Evolution
Table 192. Distributors List
Table 193. Market Trends and Market Evolution
Table 194. Market Drivers and Opportunities
Table 195. Market Challenges, Risks, and Restraints
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources

List of Figures
Figure 1. POC Diagnostics Product Picture
Figure 2. Global POC Diagnostics Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Consumables Product Picture
Figure 4. Devices Product Picture
Figure 5. Global POC Diagnostics Market Size Growth Rate by Result Format, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Qualitative POC Tests Product Picture
Figure 7. Semi-quantitative POC Tests Product Picture
Figure 8. Quantitative POC Tests Product Picture
Figure 9. Global POC Diagnostics Market Size Growth Rate by Testing Discipline, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Clinical Chemistry & Blood Gas POC Diagnostics Product Picture
Figure 11. Immunoassay POC Diagnostics Product Picture
Figure 12. Molecular POC Diagnostics Product Picture
Figure 13. Hematology POC Diagnostics Product Picture
Figure 14. Coagulation POC Diagnostics Product Picture
Figure 15. Urinalysis POC Diagnostics Product Picture
Figure 16. Global POC Diagnostics Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Hospital & Clinic
Figure 18. Laboratory
Figure 19. Household
Figure 20. Other
Figure 21. POC Diagnostics Report Years Considered
Figure 22. Global POC Diagnostics Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 24. Global POC Diagnostics Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global POC Diagnostics Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global POC Diagnostics Sales (K Units), 2021-2032
Figure 27. Global POC Diagnostics Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 28. Global POC Diagnostics Sales Market Share by Region (2021-2032)
Figure 29. Top 5 and Top 10 Manufacturers POC Diagnostics Sales Volume Market Share in 2025
Figure 30. Global POC Diagnostics Revenue-Based Market Share Ranking (2025)
Figure 31. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 32. Consumables Revenue-Based Market Share by Manufacturer in 2025
Figure 33. Devices Revenue-Based Market Share by Manufacturer in 2025
Figure 34. Global POC Diagnostics Sales Volume-Based Market Share by Type (2021-2032)
Figure 35. Global POC Diagnostics Revenue-Based Market Share by Type (2021-2032)
Figure 36. Global POC Diagnostics ASP by Type (US$/Unit), 2021-2032
Figure 37. Global POC Diagnostics Sales Volume-Based Market Share by Result Format (2021-2032)
Figure 38. Global POC Diagnostics Revenue-Based Market Share by Result Format (2021-2032)
Figure 39. Global POC Diagnostics ASP by Result Format (US$/Unit), 2021-2032
Figure 40. Global POC Diagnostics Sales Volume-Based Market Share by Testing Discipline (2021-2032)
Figure 41. Global POC Diagnostics Revenue-Based Market Share by Testing Discipline (2021-2032)
Figure 42. Global POC Diagnostics ASP by Testing Discipline (US$/Unit), 2021-2032
Figure 43. Global POC Diagnostics Sales Market Share by Application (2021-2032)
Figure 44. Global POC Diagnostics Revenue-Based Market Share by Application (2021-2032)
Figure 45. Global POC Diagnostics ASP by Application (US$/Unit), 2021-2032
Figure 46. North America POC Diagnostics Sales YoY (K Units), 2021-2032
Figure 47. North America POC Diagnostics Revenue YoY (US$ Million), 2021-2032
Figure 48. North America Top 5 Manufacturers POC Diagnostics Sales Revenue (US$ Million) in 2025
Figure 49. North America POC Diagnostics Sales Volume (K Units) by Application (2021-2032)
Figure 50. North America POC Diagnostics Sales Revenue (US$ Million) by Application (2021-2032)
Figure 51. US POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 52. Canada POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 53. Mexico POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 54. Europe POC Diagnostics Sales YoY (K Units), 2021-2032
Figure 55. Europe POC Diagnostics Revenue YoY (US$ Million), 2021-2032
Figure 56. Europe Top 5 Manufacturers POC Diagnostics Sales Revenue (US$ Million) in 2025
Figure 57. Europe POC Diagnostics Sales Volume (K Units) by Application (2021-2032)
Figure 58. Europe POC Diagnostics Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. Germany POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 60. France POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 61. U.K. POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 62. Italy POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 63. Russia POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 64. Asia-Pacific POC Diagnostics Sales YoY (K Units), 2021-2032
Figure 65. Asia-Pacific POC Diagnostics Revenue YoY (US$ Million), 2021-2032
Figure 66. Asia-Pacific Top 8 Manufacturers POC Diagnostics Sales Revenue (US$ Million) in 2025
Figure 67. Asia-Pacific POC Diagnostics Sales Volume (K Units) by Application (2021-2032)
Figure 68. Asia-Pacific POC Diagnostics Sales Revenue (US$ Million) by Application (2021-2032)
Figure 69. Indonesia POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 70. Japan POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 71. South Korea POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 72. China Taiwan POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 73. India POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 74. Central and South America POC Diagnostics Sales YoY (K Units), 2021-2032
Figure 75. Central and South America POC Diagnostics Revenue YoY (US$ Million), 2021-2032
Figure 76. Central and South America Top 5 Manufacturers POC Diagnostics Sales Revenue (US$ Million) in 2025
Figure 77. Central and South America POC Diagnostics Sales Volume (K Units) by Application (2021-2032)
Figure 78. Central and South America POC Diagnostics Sales Revenue (US$ Million) by Application (2021-2032)
Figure 79. Brazil POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 80. Argentina POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 81. Middle East, and Africa POC Diagnostics Sales YoY (K Units), 2021-2032
Figure 82. Middle East and Africa POC Diagnostics Revenue YoY (US$ Million), 2021-2032
Figure 83. Middle East and Africa Top 5 Manufacturers POC Diagnostics Sales Revenue (US$ Million) in 2025
Figure 84. Middle East and Africa POC Diagnostics Sales Volume (K Units) by Application (2021-2032)
Figure 85. Middle East and Africa POC Diagnostics Sales Revenue (US$ Million) by Application (2021-2032)
Figure 86. GCC Countries POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 87. Turkey POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 88. Egypt POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 89. South Africa POC Diagnostics Revenue (US$ Million), 2021-2032
Figure 90. POC Diagnostics Industry Chain Mapping
Figure 91. Regional POC Diagnostics Manufacturing Base Distribution (%)
Figure 92. Global POC Diagnostics Production Market Share by Region (2021-2032)
Figure 93. POC Diagnostics Production Process
Figure 94. Regional POC Diagnostics Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed